Tezacaftor | Interleukin Related interleukin-related.com

Product Name :
Tezacaftor

Search keywords :
Tezacaftor

drugId :
null

Target Vo:
Cystic fibrosis transmembrane conductance regulator

Target Vo Short Name :
CFTR

Moa_Name:
Cystic fibrosis transmembrane conductance regulator stimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Vertex Pharmaceuticals Incorporated

Active Company_Name :
Cystic Fibrosis Foundation Therapeutics

Active Indication_Name:
Cystic Fibrosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Zenocutuzumab References
Alemtuzumab medchemexpress
GPR43 Antibody: GPR43 Antibody is an unconjugated, approximately 37 kDa, rabbit-derived, anti-GPR43 polyclonal antibody. GPR43 Antibody can be used for: ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat background without labeling.

Author: Interleukin Related

Related Posts